Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-001883
Filing Date
2024-11-13
Accepted
2024-11-13 16:30:58
Documents
53
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q g084536_10q.htm   iXBRL 10-Q 1126035
2 EXHIBIT 10.1 g084536_ex10-1.htm EX-10.1 4691
3 EXHIBIT 31.1 g084536_ex31-1.htm EX-31.1 11148
4 EXHIBIT 32.1 g084536_ex32-1.htm EX-32.1 6420
  Complete submission text file 0001753926-24-001883.txt   5409744

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE chro-20240930.xsd EX-101.SCH 50650
6 XBRL CALCULATION FILE chro-20240930_cal.xml EX-101.CAL 36909
7 XBRL DEFINITION FILE chro-20240930_def.xml EX-101.DEF 170587
8 XBRL LABEL FILE chro-20240930_lab.xml EX-101.LAB 397285
9 XBRL PRESENTATION FILE chro-20240930_pre.xml EX-101.PRE 267668
56 EXTRACTED XBRL INSTANCE DOCUMENT g084536_10q_htm.xml XML 746224
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41964 | Film No.: 241454906
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)